Introduction
The prevalence of peripheral artery disease (PAD) continues to rise worldwide, largely due to the combination of aging, smoking, hypertension, and diabetes mellitus. 1, 2 Despite remarkable technological advances, along with better peri-and post-operative management, the occurrence of restenosis due to intimal hyperplasia (IH) remains the bane of vascular surgery. 3 IH starts as a physiologic healing response to injury to the blood vessel wall. The damage and dysfunction of endothelial cells (EC) lining the inner part of the vessels trigger the recruitment of leucocytes and platelets and promote fibrosis and extra cellular matrix remodeling as well as vascular smooth muscle cell (VSMC) dedifferentiation. In turn VSMC proliferate and migrate from the media to a neointima layer over the site of injury. 4, 5 The rate of restenosis after 1 year following endovascular and vascular surgery, such as angioplasty, stent insertion, and bypass surgery, is 20 to 30%. 6 The direct cell-to-cell exchange of small molecules (<1 kDa) through gap junctions shapes signaling pathways regulating many cell functions in vascular cells, including proliferation, migration and differentiation. 7 Cx43, whereas VSMC are coupled by gap junctions made of Cx43 and Cx45. [7] [8] [9] We and others showed that Cx43 promotes IH by driving VSMC's phenotypic switch 10, 11 and stimulating VSMC proliferation. [12] [13] [14] [15] Cx37 is known to play a role during vessel growth and development [16] [17] [18] and variants of the Cx37 gene are associated with human diseases. In particular, the Cx37 gene polymorphism C1019T is a diagnostic marker for cardiovascular diseases; the C allele of the C1019T polymorphism is associated with plaque formation 19 and coronary artery disease. 20 In contrast, the T allele has been reported to be associated with an increased risk of myocardial infarction 21, 22 and ischemic stroke. 23 Recently, it was shown that, in patients with coronary artery disease receiving a stent, the restenosis risk increased four-fold in carriers of the C allele (CC þ TC) than in TT homozygotes. 24 However, the role of Cx37 in IH has never been investigated. In this study, we compared the development of IH following left carotid artery ligation (CAL) 25, 26 in WT and Cx37 -/-mice. We report different kinetics of neointima formation in Cx37 -/-mice, whereby IH is initially delayed, followed by accelerated neointima formation compared to WT. Our data suggest that this effect is independent of EC and mainly due to increased levels of Cx43 in VSMC of Cx37 -/-mice. Our data support a protective role of Cx37 against VSMC proliferation and IH, which counteracts the pro-proliferative effect of Cx43. ) and WT littermates were generated by breeding heterozygote Cx37 þ/-males and females.
Methods

Animal models
WT, heterozygous and knock-out (KO) animals were identified by PCR of genomic DNA using the following primers: forward primer 5'-TGCTAGACCAGGTCCAGGAAC-3' and reverse primer: 5'-GATCT CTCGTGGGATCATTG-3' to detect Cx37-/-allele and reverse primer: 5'-GTCCCTTCGTGCCTTTATCTC-3' to detect Cx37 wild type allele. 27 Mice were housed and bred according to standard animal facility procedures. The L-NAME model was achieved as previously described 26, 27 by adding N x -Nitro-L-arginine methyl ester hydrochloride (Sigma-aldrich Chemie GmbH, Buchs, Switzerland) to drinking water at 80 mg/kg/day during 2 weeks before CAL surgery and until sacrifice.
CAL surgery
The carotid artery ligation (CAL) was performed according to the protocol developed by Kumar et al. 25 on randomized Cx37-/-and WT littermates as previously described. 26 Two-month old male mice were anesthetized with Ketamin (100 mg/kg) (Ketasol-100, Gr€ aub E. Dr For the ex-vivo vein perfusion system, 7 to 9 cm long segments of the greater saphenous vein, with an external diameter of 2.5-4 mm were divided in 2 parts. One part was immediately fixed in buffered formol (D0). The other part was perfused using our ex-vivo perfusion system (EVPS) [30] [31] [32] for 7 days at arterial pressure (100 mmHg) as previously described 32 (more details on the method can be found at: http://www.
jove.com/video/52079/procedure-for-human-saphenous-veins-ex-vivoperfusion-external). Mouse VSMC were prepared from freshly isolated aorta explants placed and maintained in DMEM supplemented with 10%FCS at 37 C, 5% CO2, 5%O2. 33 
Histomorphometry
Both left ligated or right contralateral carotids were carefully isolated and paraffin-embedded. Six-mm sections of the ligated carotid artery were cut from the ligature towards the aortic arch and stained with Hematoxylin-Eosin (HE), and Van Gieson Elastic Laminae (VGEL) for histologic and morphometric analysis. Cross sections at every 300 mm and up to 2 mm from the ligature were morphometrically analysed using the QWin software (Leica Microsystems). Total vessel, media and lumen area were calculated from lumen perimeter, internal elastic lamina (IEL) and external elastic lamina (EEL) perimeters measured on at least 6 cross sections taken every 300 mm. Total vessel area was defined as the perfect circle derived from the EEL perimeter. Lumen area was defined as the perfect circle derived from the lumen perimeter. Media area was calculated by subtracting IEL area from total vessel area. For intimal and medial thickness, 72 (12 measurements/cross section on 6 cross sections) measurements were performed. Neointima thickness was defined as the distance between the lumen and the IEL. The media thickness was defined as the distance between the IEL and the EEL. All measurements were performed by two blinded, independent investigators as already published. 26 
Immunohistochemistry
Carotid paraffin sections were immunostained using CD45 26 The PCNA, a-SKA, SM22-a, Calponin or CD45 positive signals were evaluated automatically using the ImageJ software on 10 slides per carotid and 3 to 5 carotids per conditions. DAB þ signal were quantified as follows: images were converted into 16 bit and a color thresholding based on red hue was applied to select only the brown staining. The selected staining was processed into a binary image and the number of positive pixels determined. This signal was normalized to the total pixel number composing the carotid section and expressed as a positive pixels/total vein pixels ratio. 15, 26 For
Connexin immunohistochemistry, quick-frozen carotids were cut and immunostained using rabbit anti-Cx37 (a-diagnostic A11, diluted 1:200) or rabbit anti-Cx43 (Cell Signaling; 1:200) followed by the appropriate AlexaFluor-conjugated secondary antibodies (Life Technology; 1:500).
Immunocytochemitry
VSMC immunostaining were performed on cells grown on glass coverslips and fixed for 5 min in -20 C acetone as previously described. 29 Double immunostaining for Cx37 and Cx43 were made using rabbit ; diluted 1:200) and mouse anti-Cx43 (Millipore; diluted 1:200) antibodies followed by the appropriate AlexaFluor-conjugated secondary antibodies (Life Technology; 1:500). BrdU immunostaining were performed as previously described 29, 34 using mouse anti-BrdU (BD Bioscience, 1:200).
BrdU positive nuclei were automatically detected using the ImageJ software and normalized to the total number of DAPI-positive nuclei.
29,34
Adenoviral transfer
Ad-Cx37 and Ad-Cx43 were kind gifts from Professors V. Berthoud and E. Beyer (University of Chicago, Illinois, USA). All viral vectors were amplified and purified by Vector Biolabs, (Philadelphia, PA, U.S.A.). Human VSMC were infected overnight in complete medium and collected 48 h later as previously described. 34 
Quantitative real-time PCR
Quantitative real-time PCR analysis was performed on mRNA extracted from human VSMC as previously described. 29 The primers used were as follows; human Cx43: 5'-GAACTCAAGGTTGCCCAAAC-3' (sens); 5'-TTAGAGATGGTGCTTCCCG-3' (antisense); human Cx37: 5'-ACGA GCAGTCAGATTTCG-3' (sens); 5'-GGATGAGAGCCCATTGTAG-3' (antisense); human GAPDH: 5'-AACTTTGGTATCGTGGAAGG-3' (sens); 5'-CAGTAGAGGCAGGGATGATGT-3' (antisense). Levels of expression were indicated relative to those of GAPDH.
Western blots
Aortas or carotids were reduced to powder in liquid nitrogen, and homogenized in SDS-lysis buffer as published. 27 Western blots (WB) of aortas were performed using one aorta per lane. For carotid WB, three carotids were pooled per lane. Immunoblots analyses were performed as previously described 27, 31, 35 using the following antibodies: rabbit antiConnexin43 (Cell Signaling; diluted 1:1000); rabbit anti-Cx37 (kindly provided by Pr. A. Simon 27 ; diluted 1:2500); mouse anti a-Tubulin (Sigma-Aldrich; diluted 1:5000); mouse anti P-eNOS (BD-Bioscience; diluted 1/1000), mouse anti-eNOS, (BD-Bioscience; diluted 1/1000); mouse anti P-Akt (Cell Signaling; diluted 1:2000); rabbit anti Akt (Cell Signaling; diluted 1:2000); rabbit anti P-ERK (Cell Signaling; diluted 1:2000); rabbit anti ERK (Cell Signaling; diluted 1:5000) and appropriate horseradish peroxidase-conjugated goat anti-rabbit or anti-mouse IgG (Sigma-Aldrich, diluted 1:10000). Primary VSMC were directly solubilized in Laemmli buffer as described. 27, 31, 35 To study phosphorylated forms of proteins (P-Akt, P-eNOS, P-ERK) by Western Blotting the phosphorylated and total forms were blotted on two gels ran in parallel.
Each signal was first normalized to its respective tubulin signal before calculating the ratio of phosphorylated over total. 
Statistical analysis
All experiments were quantitatively analyzed using GraphPad Prism V R 6, and results were shown as scatter plots with mean ± SEM, or box plots ± Min-Max intervals. One or two-way ANOVAS were performed followed by multiple comparisons using post-hoc Tukey test.
Results
Cx37
-/-animals are larger than WT littermates
Longitudinal follow-up of the weight of Cx37 -/-and WT littermates during a period of 3 weeks revealed that the Cx37 -/-mice are about 10%
heavier compared to WT (see Supplementary material online, Figure S1 ).
However systolic blood pressure, left kidney index and cardiac weight index were unchanged (see Supplementary material online, Figure S1 ). The caliber (lumen area or media area) of the large vessels carotid ( Figure 1 ) and aorta (see Supplementary material online, Figure S2 ) was also increased in Cx37 -/-mice compared to WT mice. However, the ratio of media over lumen area did not show any difference between the Cx37 -/-mice and WT ( Figure 1 and see Supplementary material online, Figure S2 ). Further molecular analysis performed in carotids and aortas revealed increased native protein expression of the proliferative synthetic VSMC markers a-SKA and SM22a, but not a-SMA (not shown) or Calponin in carotids ( Figure 1 ) and aortas of Cx37 -/-mice (see Supplementary material online, Figure S2 ).
Neointima formation is delayed but increased in Cx37 -/-mice
The development of IH was compared after left carotid artery ligation (CAL) in WT and Cx37 -/-mice. The neointima and media thicknesses were measured between 0.5 and 2 mm from the ligature 14 and 28 days after surgery. The areas under the curve of neointima and media thicknesses ( Figure 2A and B) , as well as the ratio of intima over media (I/M) ( Figure 2C) , were then calculated. In WT mice, CAL induced the linear development of a neointima layer 14-28 days post-ligation (Figure 2A-C) as previously observed. 26 In contrast, the neointima was nearly absent 14 days after ligation in Cx37
, but increased about 80-fold between 14 and 28 days (Figure 2A-C) . Measurements of the lumen area, as well as the internal and external elastic lamina (IEL and EEL) revealed that WT and Cx37 -/-mice underwent similar 30% constrictive remodeling at 14 days post-CAL ( Figure 2D ). As expected, this constrictive remodeling continued to increase between 14 and 28 days in WT mice. In contrast, in Cx37
-/-, the IEL remained unchanged and the EEL perimeters increased between 14 and 28 days, due to the marked increase of neointima formation between 14 and 28 days post-ligation in Cx37 -/-mice ( Figure 2D ). Overall both WT and Cx37 -/-showed a comparable reduction in lumen area as a result of CAL ( Figure 2D) . In vessels of WT mice, Cx37 is expressed between EC, which form the intima layer. 7 Nitric oxide (NO) produced in EC by the endothelial NO synthase (eNOS) has anti-inflammatory properties and protects against IH. 36 We recently showed that blocking NO production by L-NAME treatment results in massive inflammation and IH following (Figure 2A and C) . In line with these observations, P-eNOS and total eNOS levels were not altered in aortas ( Figure 3A ) and carotids ( Figure 3B ) of Cx37 -/-mice compared to WT mice, whereas total eNOS expression was gradually decreased upon CAL in WT mice ( Figure 3C ), as expected in this model. 37 The kinetic of neointima formation was closely correlated with the amount of PCNA-positive signal cells in WT and Cx37 -/-mice ( Figure   4A ), suggesting that the increased IH in Cx37 -/-mice starting 14 days after the CAL correlated with increased cell proliferation upon CAL during the 14-to 28-day period. CAL triggers transient local inflammation 3 and 7 days after the procedure. 25 To determine whether Cx37 is involved in the early inflammatory process upon CAL, CD45 immunostaining was performed 3 and 7 days post-ligation. WT mice and Cx37 -/-mice displayed similar amounts of CD45-positive cells (leucocytes) on the endothelial surface and in the adventitia layer of the ligated carotid ( Figure 4B ), suggesting no difference in the transient local inflammation triggered by CAL in Cx37 -/-mice.
Cx37 is expressed in the media but not in the neointima layer of ligated carotids
To further characterize the role of Cx37 in IH following CAL, immunolocalization of Cx37 was performed in carotids of WT mice submitted to the CAL model. Cx37 was mainly detected in the intima layer at d0 ( Figure 5A ). Cx37 may also be expressed at very low levels in the media layer. However it was difficult to ascertain the presence of Cx37 in the VSMC of aortas when compared to non-specific staining detected in the Figure S3 ).
28 days post-ligation, Cx37 remained expressed in the intima and was strongly up-regulated in the media layer, but was absent in the neointima layer of ligated carotids ( Figure 5A ). Similar observations were also made in human veins perfused for 7 days in arterial conditions to stimulate the development of intimal hyperplasia (Figure 5B) . In contrast, Cx43, the main Connexin expressed in VSMC, was expressed in the media layer at d0, and was up-regulated in the media and neointima layers 14 or 28 days post CAL, leading to a two-fold increased in Cx43 levels 28 days post CAL ( Figure 5C-D) . Moreover, the basal levels of Cx43 were increased about 50% in carotids and aortas of Cx37 -/-compared to WT mice ( Figure 5C -E). 
Cx37 expression in VSMC destabilizes Cx43
To determine the impact of the presence of Cx37 in VSMC, Cx37 was expressed in primary human VSMC. Adenoviral-driven de novo expression of Cx37 in VSMC resulted in a dose-dependent increase of Cx37 levels in the VSMC membrane ( Figure 6A) . The presence of Cx37 was associated with a 30% reduction in the number of BrdU-positive cells over a 16-h period ( Figure 6B ) and reduced VSMC migration in a model of wound healing, as compared to non-infected (NI) VSMC or VSMC infected with the control adenovirus (Ad-GFP) (see Supplementary material online, Figure S4) . Similarly, primary VSMC derived from Cx37 -/-aortas proliferate faster than that of WT mouse ( Figure 6C) . The expression of Cx37 in VSMC was associated with a decreased Cx43 protein levels ( Figure 7A ), but not the levels of the cognate GJA1 transcript ( Figure 7B) . Immunostaining experiments further revealed that the Cx43 immunolabeling at the membrane was lost in cells expressing Cx37 ( Figure 7C) , suggesting that the presence of Cx37 in VSMC destabilizes Cx43-made gap junctions. However, time-course experiments of cycloheximide treatment (CHX; 10 mg/mL) to block translation in VSMC infected with a control adenovirus (Ad-GFP) or the Cx37 adenovirus (Ad-Cx37) suggested that Cx37 expression do not reduce the half-life of Cx43 ( Figure 7D) . The Akt pathway, which plays a crucial role in cell proliferation, is known to promote Cx43 stability. 38, 39 Here, we observed that adenoviral-mediated Cx43 overexpression stimulated ERK and Akt phosphorylation in VSMC ( Figure 8A) . In contrast, Cx37 expression reduced the P-Akt levels, but did not alter the P-ERK levels ( Figure 8B) , suggesting that the ratio between Cx43/Cx37 expression in VSMC regulates the Akt activity. Moreover, the basal P-ERK and P-Akt levels were also increased in the carotid of Cx37 -/-mice ( Figure 8C) . Finally, in human VSMC, inhibition of Akt using 5 mM MK2206 (Akti) for 6h significantly decreased Cx43 levels while increasing Cx37 levels. MK2206 did not further decreased Cx43 levels when Cx37 was overexpressed using AdCx37. Of note, blocking lysosomal activity using the vacuolar-type Hþ-ATPase (V-ATPase) inhibitor Bafilomycin A1 (Baf; 50 nM) for 6h increased basal Cx43 levels and prevented the Cx43 down-regulation upon Cx37 overexpression, indicating that Cx43 diminution upon Cx37 overexpression requires protein degradation ( Figure 8D ). 
Discussion
The present study reports that loss of Cx37 delays but eventually exacerbates neointima formation in a model of carotid artery ligation, suggesting that Cx37 plays mostly a protective role during the development of intimal hyperplasia (IH). Cx37 deficient mice (Cx37 -/-) are slightly bigger than their WT littermates, resulting in larger carotids and aortas in Cx37 -/-mice. This observation is in accordance with previous studies showing that Cx37 -/-mice have increased bone mass. 40, 41 These larger vessels also display molecular evidences that the phenotype of the VSMC forming the media layer of large arteries in Cx37 -/-is altered. Thus, the basal level of a-SKA, a marker of synthetic proliferative VSMC associated with IH and restenosis, 5 is increased in the media of Cx37 -/-mice.
However, the basal level of SM22a, which is usually downregulated within neointimal VSMC, 42 is also increased in the media layer of carotids and aortas, whereas another major contractile marker, a-SMA, remains unchanged. The absence of Cx37 in vessels is also associated with increased basal P-Akt levels, a key up-regulator of cell survival, proliferation and growth, 43 especially in VSMC. 44, 45 Cx43, the major Connexin expressed in VSMC, is also increased in Cx37 -/-mice. Of note, Cx43 overexpression is a known feature of IH in vascular occlusive animal models 15, 46, 47 and in human saphenous veins 15, 48 associated with increased VSMC proliferation and migration. 10, 11, [13] [14] [15] These results suggest that, independently of any lesion or vascular pathology, the absence of Cx37 correlates with molecular signs of vasculopathy. In accordance with this hypothesis, Cx37 overexpression in vitro in primary human VSMC decreased proliferation, supporting a growth-suppressive effect of Cx37 in the vasculature, which may also explain the increased caliber of Cx37 -/-vessels.
Although IH was more pronounced in Cx37 -/-mice 28 days after the CAL surgery, a delayed development of IH was observed during the first 14 days, suggesting an initial protective effect. This was unexpected since Cx37 -/-mice have been shown to display increased monocyte and macrophage recruitment to the vascular wall in the ApoE-deficient mouse model of atherosclerosis, 19 suggesting that Cx37 has anti-inflammatory properties. However, in our model, Cx37 deficiency did not impact the infiltration of CD45-positive cells, suggesting that Cx37 is not involved in the initial inflammatory process triggered by CAL. This early inflammatory phase is largely due to EC dysfunction as a result of ligation trauma and the drop in hemodynamic forces. 25, 37 We recently demonstrated that EC-derived NO deficiency is a major trigger of vascular inflammation following CAL. 26 In the present study, Cx37 -/-mice were as sensitive to L-NAME treatment as WT mice, suggesting no major initial NO and EC dysfunction in Cx37 -/-mice. In line with these findings the levels of eNOS were not modified in aortas and carotids of Cx37 -/-mice compared to WT mice. Thus, our data suggest that, in this model, the role of Cx37 in IH is not related to EC and NO dysfunction. It is therefore likely that Cx37 plays a role in IH through its expression in VSMC, which is barely detectable in the media of large vessels of nonoperated animals, but largely up-regulated upon CAL, specifically in the media layer but not in the VSMC-rich neointima layer. A similar increase in Cx37 levels was observed in human veins placed in arterial condition using our ex-vivo model of vein perfusion. 15, 31 Cx37 up-regulation in the media layer is also a hallmark of hypertension in mice 27, 35, 49 and Cx37 expression is also increased in VSMC during arteriogenesis in a model of coronary collateral vessel growth after occlusion. 18, 50 Our observation that Cx37 -/-mice express altered levels of key VSMC markers such as a-SKA and SM22a further supports a regulatory role of Cx37 in the media during development and during pathological arterial remodeling. Forced expression of Cx37 in primary human VSMC devoid of detectable Cx37 expression inhibited VSMC proliferation, suggesting a protective role of Cx37 against pathological VSMC proliferation. Interestingly, this effect is opposite to that of Cx43, which is highly expressed both in the media layer, and especially in the neointima layer, and associated with increased cell proliferation. 10, 11, [13] [14] [15] Cx37 overexpression in VSMC decreases Cx43 at the plasma membrane, suggesting that Cx37 interferes with the formation of Cx43 gap junctions. The activity and stability of Cx43 gap junctions are regulated by the MAPK and Akt pathways. 38, 39 Here, we confirm that Akt positively regulates Cx43, and show for the first time, that Cx43 overexpression increases P-Akt level, whereas Cx37 expression decreases it. Given the prominent role of the Akt pathway in IH, 45, [51] [52] [53] the fact that Cx43 overexpression stimulates Akt phosphorylation likely contributes to VSMC proliferation and may induce a pathological positive feedback loop of Cx43 stabilization. Our data suggest that the phenotype of VSMC is altered in absence of Cx37. However, since Cx37 deletion results in Cx43 up-regulation, one may not dissociate the role of Cx37 from the well documented deleterious role of Cx43 in VSMC proliferation and migration in the context of IH. 10, 11, [13] [14] [15] While we propose that Cx37 up-regulation in the media layer upon CAL counteracts the proproliferative effect of Cx43, further studies are required to better characterize the balance between Akt, Cx43, and Cx37 and to determine the specific role of Cx37 independently of Cx43. In summary, our findings document that Cx37 deficiency enhances CAL-induced IH in association with increased VSMC proliferation and increased levels of Cx43 and P-Akt in Cx37 -/-mice. This study highlights a specific role of Cx37 in VSMC, which may play a crucial role to maintain normal VSMC phenotype and counteracts cell proliferation in pathological conditions. Further studies aimed at understanding how Cx37 is overexpressed in the media and not in the neointima layer might prove useful to exploit the protective properties of Cx37 against IH for therapeutic purposes.
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